Company Filing History:
6 out of 52 
1 out of 1,271 
1 out of 15,488 
Years Active: 1997-2001
Title: The Innovative Contributions of Anthony J Pawson
Introduction
Anthony J Pawson is a prominent inventor based in Toronto, Canada, known for his significant contributions to the field of molecular biology. He holds a total of seven patents, showcasing his innovative spirit and dedication to advancing scientific knowledge. His work primarily focuses on receptor tyrosine kinases and their role in cellular signaling.
Latest Patents
Among his latest patents, Pawson has developed a novel receptor tyrosine kinase protein and its isoforms, which are expressed in migrating axons. This invention includes nucleic acid molecules encoding the novel protein isoforms and parts thereof. The patent also describes methods for identifying substances capable of binding to the receptor protein, as well as screening for agonists or antagonists of the binding. Additionally, diagnostic and therapeutic methods utilizing the protein and nucleic acid molecules are outlined. Another significant patent involves Shc proteins, characterized by a C-terminal Src homology 2 (SH2) domain, a central proline-rich region (CH1), and an N-terminal phosphotyrosine binding (PTB) domain. These proteins are predominantly expressed in the adult brain and play a crucial role in mediating signaling from tyrosine kinases in the nervous system.
Career Highlights
Pawson has had a distinguished career, working with notable institutions such as Mount Sinai Hospital Corporation and the University of North Carolina at Chapel Hill. His research has significantly impacted the understanding of cellular signaling pathways and their implications in various biological processes.
Collaborations
Throughout his career, Pawson has collaborated with esteemed colleagues, including Channing J Der and John O'Bryan. These collaborations have further enriched his research and contributed to the advancement of knowledge in his field.
Conclusion
Anthony J Pawson's innovative work in the realm of receptor tyrosine kinases and Shc proteins has made a lasting impact on molecular biology. His patents and collaborations reflect his commitment to scientific advancement and the betterment of human health.